A detailed history of Wells Fargo & Company transactions in Chroma Dex Corp. stock. As of the latest transaction made, Wells Fargo & Company holds 1,607 shares of CDXC stock, worth $4,467. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,607
Previous 1,600 0.44%
Holding current value
$4,467
Previous $2,000 150.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$1.36 - $3.84 $9 - $26
7 Added 0.44%
1,607 $5,000
Q4 2023

Feb 09, 2024

BUY
$1.28 - $1.6 $26 - $33
21 Added 1.33%
1,600 $2,000
Q3 2023

Nov 13, 2023

SELL
$1.36 - $1.77 $21 - $28
-16 Reduced 1.0%
1,579 $2,000
Q2 2023

Aug 15, 2023

BUY
$1.31 - $1.79 $24 - $34
19 Added 1.21%
1,595 $2,000
Q1 2023

May 12, 2023

BUY
$1.48 - $2.19 $7 - $10
5 Added 0.32%
1,576 $2,000
Q4 2022

Feb 13, 2023

BUY
$1.46 - $1.94 $56 - $75
39 Added 2.55%
1,571 $2,000
Q3 2022

Nov 14, 2022

SELL
$1.21 - $2.06 $42 - $72
-35 Reduced 2.23%
1,532 $1,000
Q2 2022

Aug 12, 2022

SELL
$1.59 - $2.7 $129,662 - $220,182
-81,549 Reduced 98.11%
1,567 $3,000
Q1 2022

May 16, 2022

SELL
$2.02 - $3.92 $24,619 - $47,776
-12,188 Reduced 12.79%
83,116 $204,000
Q4 2021

Feb 14, 2022

BUY
$3.74 - $6.7 $62,166 - $111,367
16,622 Added 21.13%
95,304 $356,000
Q3 2021

Nov 15, 2021

BUY
$6.05 - $10.41 $279,086 - $480,213
46,130 Added 141.71%
78,682 $494,000
Q2 2021

Aug 16, 2021

SELL
$6.66 - $10.92 $720,132 - $1.18 Million
-108,128 Reduced 76.86%
32,552 $320,000
Q1 2021

May 13, 2021

BUY
$4.59 - $18.74 $152,709 - $623,479
33,270 Added 30.97%
140,680 $1.31 Million
Q4 2020

Feb 09, 2021

SELL
$3.93 - $5.5 $17,523 - $24,524
-4,459 Reduced 3.99%
107,410 $516,000
Q3 2020

Nov 05, 2020

BUY
$4.01 - $5.56 $33,158 - $45,975
8,269 Added 7.98%
111,869 $449,000
Q2 2020

Aug 13, 2020

BUY
$3.0 - $5.52 $80,514 - $148,145
26,838 Added 34.96%
103,600 $476,000
Q1 2020

May 14, 2020

BUY
$2.54 - $4.75 $194,975 - $364,619
76,762 New
76,762 $251,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $190M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.